logo

MEDICAMEQ vs VIYASH: Stock Comparison

MEDICAMEQ vs VIYASH SCIENTIFICUpdated 17 Sept 26, 4:08 PM ISTNSE & company filings

VIYASH SCIENTIFIC is the larger company by market capitalisation. MEDICAMEQ shows a lower P/E, a higher dividend yield and faster revenue growth, while VIYASH SCIENTIFIC shows a higher ROE, a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

MEDICAMEQ leads 7; VIYASH leads 4 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

MEDICAMEQVIYASH

Valuation lens

What price are you paying?

Market CapContext only
₹362 Cr
₹9,199 Cr
P/E RatioMEDICAMEQ has the lower reading
36.16x ✓
49.82x
P/B RatioMEDICAMEQ has the lower reading
1.42x ✓
3.12x
EPSMEDICAMEQ has the higher reading
₹1.56 ✓
₹1.51
Book ValueContext only
₹203.17
₹71.3
Dividend YieldMEDICAMEQ has the higher reading
0.37% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
VIYASH is the larger company
₹9,199 Cr vs ₹362 Cr
P/E Ratio
MEDICAMEQ has a lower P/E
36.16x vs 49.82x
P/B Ratio
MEDICAMEQ has a lower P/B
1.42x vs 3.12x
EPS
MEDICAMEQ has higher earnings per share
₹1.56 vs ₹1.51
Dividend Yield
MEDICAMEQ has a higher dividend yield
0.37% vs 0%
Revenue Growth (TTM YoY)
MEDICAMEQ has faster revenue growth
80.2% vs 0%
EPS Growth (TTM YoY)
MEDICAMEQ has faster EPS growth
44.7% vs 0%
ROE
VIYASH has a higher ROE
7.21% vs 3.36%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMEDICAMEQVIYASH
SectorHealthcare—
IndustryPharmaceuticals—

Price

MetricMEDICAMEQVIYASH
Live Price₹346.3₹207.99
Day Change0.23%-2.62%
Volume1.29 L21.17 L
52-Week High₹447.65₹298
52-Week Low₹212.4₹178.13
Distance from 52W High-22.64%-30.2%

Valuation

MetricMEDICAMEQVIYASH
Market Cap₹362 Cr₹9,199 Cr
P/E Ratio36.16x49.82x
P/B Ratio1.42x3.12x
EPS₹1.56₹1.51
Book Value₹203.17₹71.3
Dividend Yield0.37%0%

Growth

MetricMEDICAMEQVIYASH
Revenue Growth (TTM YoY)80.2%0%
EPS Growth (TTM YoY)44.7%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricMEDICAMEQVIYASH
ROE3.36%7.21%
ROCE4.09%8.17%
Net Margin5.21%6.57%
Operating Margin8.01%12.23%
Debt to Equity0.13x0.14x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricMEDICAMEQVIYASH
Promoter Holding40.46%0%
FII Holding0.07%▼ 0.03 pp2.6%▼ 1.9 pp
DII Holding0.4%▲ 0.4 pp8.3%▲ 4.55 pp
Public Holding59.02%▼ 0.37 pp39.76%▲ 9.42 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: MEDICAMEQ and VIYASH SCIENTIFIC.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.